Evidence map›Paper›PMID 36313967›Full record

ArticleAlzheimer's & dementia (New York, N. Y.)2022

Transcriptional profiles in olfactory pathway-associated brain regions of African green monkeys: Associations with age and Alzheimer's disease neuropathology.

Jacob D Negrey, Dorothy L Dobbins, Timothy D Howard, Karin E Borgmann-Winter, Chang-Gyu Hahn, Sergey Kalinin, Douglas L Feinstein, Suzanne Craft, Carol A Shively, Thomas C Register

Open access · goldAbstract read
In one paragraph

Article in Alzheimer's & dementia (New York, N. Y.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Plasma and CSF biomarkers of aging and cognitive decline in Caribbean vervets.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Jacob D NegreyDepartment of Pathology/Comparative Medicine Wake Forest School of Medicine Winston-Salem North Carolina USA.
Dorothy L DobbinsDepartment of Pathology/Comparative Medicine Wake Forest School of Medicine Winston-Salem North Carolina USA.
Timothy D HowardDepartment of Biochemistry Wake Forest School of Medicine Winston-Salem North Carolina USA.
Karin E Borgmann-WinterDepartment of Psychiatry Department of Neuroscience Thomas Jefferson University Philadelphia PA USA.
Chang-Gyu HahnDepartment of Psychiatry Department of Neuroscience Thomas Jefferson University Philadelphia PA USA.
Sergey KalininDepartment of Anesthesiology University of Illinois Chicago Illinois USA.
Douglas L FeinsteinDepartment of Anesthesiology University of Illinois Chicago Illinois USA.
Suzanne CraftDepartment of Internal Medicine/Gerontology and Geriatric Medicine Wake Forest School of Medicine Winston-Salem North Carolina USA.
Carol A ShivelyDepartment of Pathology/Comparative Medicine Wake Forest School of Medicine Winston-Salem North Carolina USA.
Thomas C RegisterDepartment of Pathology/Comparative Medicine Wake Forest School of Medicine Winston-Salem North Carolina USA.
Wake Forest University · USThomas Jefferson University · USJesse Brown VA Medical Center · USUniversity of Illinois Chicago · US

Funding

Wake Forest Claude D. Pepper OAIC - RenewalP30AG021332 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Denise Kathryn Houston · 2002 to 2026
$36.4M
Wake Forest University School of Medicine Alzheimer's Disease Research CenterP30AG072947 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI SUZANNE CRAFT · 2021 to 2026
$24.3M
Vervet Research Colony as a Biomedical ResourceP40OD010965 · OD · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Matthew Jorgensen · 2012 to 2026
$14.6M
Wake Forest Alzheimer's Disease Core CenterP30AG049638 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ESPELAND, MARK ANDREW · 2016 to 2020
$12.2M
Development of an Innovative Vervet (Chlorocebus aethiops sabaeus) Model of Early Alzheimer's-like Neuropathology and SymptomatologyR24AG073199 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI CRAFT, SUZANNE, SHIVELY, CAROL A. · 2021 to 2024
$5.6M
Effects of Western and Mediterranean Diets on Metabolic and Neuropathologic Risk Factors for Alzheimer's Disease in Nonhuman PrimatesRF1AG058829 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI CRAFT, SUZANNE, SHIVELY, CAROL A. · 2018 to 2018
$2.8M
Social Stress, Diet. and Primate Monocyte Programming in Cardiovascular RiskR01HL122393 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI REGISTER, THOMAS COSTIN, SHIVELY, CAROL A. · 2015 to 2018
$2.0M
NHLBI NIH HHS R01 HL122393NIA NIH HHS P30 AG021332NIA NIH HHS P30 AG049638NIA NIH HHS P30 AG072947NIA NIH HHS R24 AG073199NIA NIH HHS RF1 AG058829NIH HHS P40 OD010965
6 · The paper itself

Abstract

Introduction: Olfactory impairment in older individuals is associated with an increased risk of Alzheimer's disease (AD). Characterization of age versus neuropathology-associated changes in the brain olfactory pathway may elucidate processes underlying early AD pathogenesis. Here, we report age versus AD neuropathology-associated differential transcription in four brain regions in the olfactory pathway of 10 female African green monkeys (vervet, Methods: Transcriptional profiles were determined by microarray in the olfactory bulb (OB), piriform cortex (PC), temporal lobe white matter (WM), and inferior temporal cortex (ITC). Amyloid beta (Aβ) plaque load in parietal and temporal cortex was determined by immunohistochemistry, and concentrations of Aβ42, Aβ40, and norepinephrine in ITC were determined by enzyme-linked immuosorbent assay (ELISA). Transcriptional profiles were compared between middle-aged and old animals, and associations with AD-relevant neuropathological measures were determined. Results: Transcriptional profiles varied by brain region and age group. Expression levels of Discussion: These data demonstrate age differences in gene expression in olfaction-associated brain regions. Biological processes exhibiting age-related enrichment included the regulation of cell death, vascular function, mitochondrial function, and proteostasis. A subset of DEGs was specifically associated with AD phenotypes. These may represent promising targets for future mechanistic investigations and perhaps therapeutic intervention.

Indexed as

agingAlzheimer's diseasemRNAnonhuman primatesolfactory pathwaytranscriptomicsvervet

Identifiers

PMID36313967
PMCPMC9609452
OpenAlexW4307967744

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.